Novoprotein Scientific

Novoprotein Scientific EBIT

The EBIT of Novoprotein Scientific (688137.SS) as of Oct 29, 2026 is -66.69 M CNY. In the previous year, EBIT was -55.40 M CNY — a change of 20.37% (lower).

EBIT

-66.69 MCNY

YoY

20.37%

Last updated:

In 2025, Novoprotein Scientific's EBIT was -66.69 M CNY, a 20.37% increase from the -55.40 M CNY EBIT recorded in the previous year.

The Novoprotein Scientific EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2019
-8.80 M CNY
Jan 1, 2020
95.13 M CNY
Jan 1, 2021
193.86 M CNY
Jan 1, 2022
112.92 M CNY
Jan 1, 2023
-5.89 M CNY
Jan 1, 2024
-55.40 M CNY
Jan 1, 2025
-66.69 M CNY
The Novoprotein Scientific EBIT history
YEAREBITYoY
-66.69 MCNY+20.37%
-55.40 MCNY+840.30%
-5.89 MCNY-105.22%
112.92 MCNY-41.75%
193.86 MCNY+103.78%
95.13 MCNY-1,181.03%
-8.80 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Novoprotein Scientific Revenue

Novoprotein Scientific Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
36.00 M CNY
-8.80 M CNY
-8.50 M CNY
Jan 1, 2020
179.84 M CNY
95.13 M CNY
83.05 M CNY
Jan 1, 2021
341.90 M CNY
193.86 M CNY
149.01 M CNY
Jan 1, 2022
264.55 M CNY
112.92 M CNY
90.72 M CNY
Jan 1, 2023
153.19 M CNY
-5.89 M CNY
12.84 M CNY
Jan 1, 2024
127.56 M CNY
-55.40 M CNY
-54.42 M CNY
Jan 1, 2025
146.44 M CNY
-66.69 M CNY
-77.78 M CNY

Novoprotein Scientific Margins

Novoprotein Scientific stock margins

The Novoprotein Scientific margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Novoprotein Scientific. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Novoprotein Scientific.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
63.89 %
-24.44 %
-23.61 %
Jan 1, 2020
89.26 %
52.90 %
46.18 %
Jan 1, 2021
87.69 %
56.70 %
43.58 %
Jan 1, 2022
86.32 %
42.68 %
34.29 %
Jan 1, 2023
75.67 %
-3.85 %
8.38 %
Jan 1, 2024
62.38 %
-43.43 %
-42.66 %
Jan 1, 2025
67.12 %
-45.54 %
-53.12 %

Novoprotein Scientific Stock analysis

What does Novoprotein Scientific do? Novoprotein Scientific Inc generates revenue through the development, production, and sale of recombinant protein solutions. The company offers target and factor proteins, recombinant antibodies, enzymes, and reagents, along with technical services. Its main products include novel coronavirus diagnostic antibodies, antigens, pseudoviruses, non-structural proteins, and mRNA raw material enzymes and reagents. These products are primarily sold to customers in biological medicine, life science research, in vitro diagnostics, and mRNA vaccine drug sectors. The firm serves both domestic and international markets with its comprehensive portfolio of protein-based solutions. The company's revenue streams are derived from the sale of specialized biological reagents and technical services. Customers in the pharmaceutical and biotechnology industries purchase these products for research and diagnostic applications. The firm's focus on novel coronavirus-related products positions it within the healthcare and vaccine development markets. Novoprotein Scientific Inc targets both domestic Chinese and overseas markets for its protein application solutions. Novoprotein Scientific Inc's business model centers on providing high-value recombinant protein products and services for the life science and healthcare sectors. The company's product portfolio includes diagnostic tools for viral detection and mRNA vaccine components. These offerings are tailored to meet the needs of research institutions, diagnostic laboratories, and pharmaceutical companies. The firm's technical services support customers in developing and implementing protein-based solutions across multiple applications. Novoprotein Scientific is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Novoprotein Scientific's EBIT

Novoprotein Scientific's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Novoprotein Scientific's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Novoprotein Scientific's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Novoprotein Scientific’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Novoprotein Scientific stock

EBIT of Novoprotein Scientific is -66.69 M CNY in 2025.

EBIT of Novoprotein Scientific changed from -55.40 M CNY to -66.69 M CNY, representing a 20.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Novoprotein Scientific since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Novoprotein Scientific historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Novoprotein Scientific

All Key Metrics — Novoprotein Scientific